Chemical Structure (Balversa 01)
Balversa Tablet, Film Coated
Product Images NDC 59676-040
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Balversa (NDC 59676-040). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Janssen Products Lp, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Principal Display Panel (3 mg Tablet Bottle Carton)
Balversa (erdafitinib) is a prescription-only medication in the form of film-coated tablets containing 3mg erdafitinib. The recommended dosage information can be obtained from the prescribing information of the medication. The package is designed to be child-resistant and should be kept out of reach of children. Balversa should be stored at temperatures between 20°C-25C (68°F-77°F) with excursions between 15°C and 30°C (59°F and 86°F) permitted. The product is manufactured in Switzerland and distributed by Janssen Products in Horsham, PA. The NDC code for the product is 59676-030-56.*
Principal Display Panel (4 mg Tablet Bottle Carton)
Balversa (erdafitinib) tablets are only available through prescription. The package is child-resistant and should be kept out of children’s reach. Store tablets at a controlled room temperature between 20°C-25°C (68°F-77°F) with excursions permitted between 15°C and 30°C (59°F and 86°F) and refer to the prescribing information for the recommended dosage. Each film-coated Balversa tablet contains 4 mg of erdafitinib. This is a product of Switzerland manufactured for Janssen Products in Horsham, PA. The product cannot be evaluated if any is filled with Non-English characters.*
Principal Display Panel (5 mg Tablet Bottle Carton)
This is a package of 28 film-coated tablets of Balversa (erdafitinib) which are only available through prescription. The recommended dosage is not given and it refers readers to see the prescribing information. The tablets are child-resistant and should be stored between 15°C and 30°C (59°F and 86°F). Each film-coated tablet contains 5 mg of erdafitinib manufactured by Janssen Products in Switzerland. The product is distributed by Janssen Products in Horsham, PA 19044.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
